Figure 2.
RNAi-induced down-regulation of FLT3 sensitizes Ba/F3 FLT3-ITD transfectants and Molm-14 cells to treatment with MLN518. (A) Dose-dependent decrease in cell proliferation following treatment with decreasing concentrations of FLT3 siRNA (Ba/F3 FLT3-ITD cells [n = 8] and Molm-14 cells [n = 5]). (B) Treating Ba/F3 FLT3-ITD cells (n = 8) and Molm-14 cells (n = 5) with FLT3 siRNA increases their sensitivity to treatment with the FLT3 inhibitor MLN518. Error bars indicate standard deviation.